Rashad Ismayılov

25PUBLICATIONS

89CO-AUTHORS

Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markersHaematological tumoursClinical pharmacy and pharmacy practice

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jun 30, 2026

Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.

|Jun 24, 2026

High prevalence of colistin heteroresistance in Pseudomonas aeruginosa bloodstream isolates and associated clinical factors.

|Jun 15, 2026

Time-dependent prognostic impact of distant metastatic sites in small cell lung cancer: a comparative analysis of pre- and post-immunotherapy eras.

|Jun 12, 2026

Prognostic Implications of Chronic Kidney Disease in Colorectal Cancer Surgery: A Propensity Score-Matched Analysis.

|Apr 13, 2026

RE: An immunosuppressive tertiary lymphoid structure is associated with adverse prognosis in gastric-type endocervical adenocarcinoma.

Rashad Ismayilov, Ozden Altundag

|Mar 09, 2026

Beyond linearity and static risk: re-evaluating core prognostic factors in diffuse large B-cell lymphoma.

Rashad Ismayilov, Murat Ozdede, Yahya Buyukasik

Pageof 5

Frequent Collaborators

Arif Akyıldız

Ozden Altundag

Arzu Oguz

Zafer Akcali

Murat Ozdede

Esra Arzu Gencoglu

Mert Tokatlı

Zafer Arık

Hasan Cagri Yıldırım

Ibrahim Barista

Frequent Collaborators

Arif Akyıldız

Ozden Altundag

Arzu Oguz

Zafer Akcali